Printer Friendly

BARR-ICI SETTLEMENT IS FINALIZED

 POMONA, N.Y., April 14 /PRNewswire/ -- The final steps in clearing the way for a previously announced out-of-court settlement of a patent dispute involving Imperial Chemical Industries PLC's (NYSE: ICI) U.S. patent on tamoxifen citrate have been successfully completed, it was announced today by Barr Laboratories, Inc. (AMEX: BRL), Pomona.
 The settlement agreement, announced on March 8, 1993, was contingent upon satisfying several conditions. All contingencies have now been satisfied.
 Under terms of the settlement agreement, ICI paid Barr Laboratories a total cash payment of $21 million and Barr entered into a non- exclusive distributorship agreement with ZENECA, Inc., a U.S. affiliate of ICI. Barr will begin selling generic tamoxifen citrate as of Nov. 1, 1993.
 With the dismissal of the appeal and vacation of the judgment, ICI's patent on Nolvadex(R) has been restored. The patent will not expire until 2002.
 -0- 4/14/93
 /CONTACT: Harold Cohen of Barr, 914-362-2823; or Jeffrey Soper of ZENECA, 302-886-7433/
 (BRL)


CO: Barr Laboratories, Inc.; Imperial Chemical Industries PLC;
 ZENECA, Inc. ST: New York IN: MTC SU:


GK-OS -- NY046 -- 5660 04/14/93 11:32 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 14, 1993
Words:186
Previous Article:SIDLEY & AUSTIN ANNOUNCES 24 NEW PARTNERS
Next Article:MOUNTAINEER BANKSHARES OF W.VA., INC. ANNOUNCES INCREASED FIRST QUARTER EARNINGS
Topics:


Related Articles
ICI AND MONSANTO SETTLE PATENT DISPUTE ON SAFENERS AND CONCLUDE REGULATORY AND PRODUCTION AGREEMENTS ON ACETOCHLOR
ICI AND BARR LABORATORIES SETTLE SUIT CONCERNING LEADING BREAST CANCER MEDICATION
IMPERIAL CHEMICAL INDUSTRIES PLC ZENECA DEMERGER APPROVED AT EXTRAORDINARY GENERAL MEETING
ICI To Sell Polyester and Tioxide Businesses for US$3 Billion
ICI Agrees US$3 Billion Disposal To DuPont; ICI Divestment Program Reaches 2.9 Billion Pounds
Huntsman ICI Holdings to Acquire 100% of Wilton Olefins Cracker.
Gas leak may add pounds 1.4m to ICI bill.
ICI to sell This Old House paint brand.
Barr Announces Launch of Ciprofloxacin Products; Company to Distribute Alternative Brand Products Under Supply Agreement With Bayer.
Akzo Nobel restructures company following merger with ICI.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters